Approvals/NMPA/Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

Approved

化学药品

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

辰欣药业股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8n6FX84EK47
Approval Number: 国药准字H20264126
Generic Name: 达格列净二甲双胍缓释片(Ⅰ)
Generic Name En: Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含达格列净10mg(按C₂₁H₂₅ClO₆计)与盐酸二甲双胍1000mg
Reg Date: 2026-04-21
Company Name: 辰欣药业股份有限公司
Company Address: 济宁高新区同济科技工业园
Production Company Name: 辰欣药业股份有限公司
Production Company Address: 济宁高新区海川路
Company Detail Path: /organization/cisen-pharmaceutical-co-ltd
Production Company Detail Path: /organization/cisen-pharmaceutical-co-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 21, 2026

Approval ID

8n6FX84EK47

Type

化学药品